Browsing by Author Huang, Wenxiang

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)
2013A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in ChinaYang, Qiwen; Zhang, Hui; Wang, Yao; Xu, Yingchun; Chen, Minjun; Badal, Robert E.; Wang, Hui; Ni, Yuxing; Yu, Yunsong; Hu, Bijie; Sun, Ziyong; Huang, Wenxiang; Wang, Yong; Wu, Anhua; Feng, Xianju; Liao, Kang; Shen, Dingxia; Hu, Zhidong; Chu, Yunzhuo; Lu, Juan; Cao, Bin; Su, Jianrong; Gui, Bingdong; Duan, Qiong; Zhang, Shufang; Shao, Haifeng; Kong, Haishen; Hu, Yunjian; Ye, Huifen
2019All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in chinaWei, Lai; Xu, Xiaoyuan; Guan, Yujuan; Zheng, Sujun; Sheng, Ji-Fang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Ji-Dong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojong; Zhang, Quan; Hu, Peng; Wang, Fu-Sheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi
2018Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in ChinaWei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei
2018Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in ChinaWei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei
2019Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naive Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in ChinaXu, Xiaoyuan; Feng, Bo; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; Anl, Ping; Gong, Guozhong; Liu, Huimin; Nine, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, Fusheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi J.; Wei, Lai
2019THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIALWei, Lai; Xu, Xiaoyuan; Zheng, Sujun; Guan, Yujuan; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qing; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang, Sr.; Chen, Liang; Ye, Yinong, Sr.; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi
2016HBsAg and HBeAg in the prediction of a clinical response to peginterferon alpha-2b therapy in Chinese HBeAg-positive patientsYang, Song; Xing, Huichun; Wang, Yuming; Hou, Jinlin; Luo, Duande; Xie, Qing; Ning, Qin; Ren, Hong; Ding, Huiguo; Sheng, Jifang; Wei, Lai; Chen, Shijun; Fan, Xiaoling; Huang, Wenxiang; Pan, Chen; Gao, Zhiliang; Zhang, Jiming; Zhou, Boping; Chen, Guofeng; Wan, Mobin; Tang, Hong; Wang, Guiqiang; Yang, Yuxiu; Xu, Dongping; Dong, Peiling; Wang, Qixin; Wang, Jue; Bognar, Fernando A.; Xu, Daozhen; Cheng, Jun
2014Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trialCheng, Jun; Wang, Yuming; Hou, Jinlin; Luo, Duande; Xie, Qing; Ning, Qin; Ren, Hong; Ding, Huiguo; Sheng, Jifang; Wei, Lai; Chen, Shijun; Fan, Xiaoling; Huang, Wenxiang; Pan, Chen; Gao, Zhiliang; Zhang, Jiming; Zhou, Boping; Chen, Guofeng; Wan, Mobin; Tang, Hong; Wang, Guiqiang; Yang, Yuxiu; Mohamed, Rosmawati; Guan, Richard; Lee, Tzong-Hsi; Chang, Wen-Hsiung; Huang Zhenfei; Ye, Zhang; Xu, Daozhen
2010A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial InfectionsWang, Jin; Xiao, Yonghong; Huang, Wenxiang; Xu, Nan; Bai, Chunxue; Xiu, Qingyu; Mei, Changlin; Zheng, Qingshan
Apr-2023Physicians' knowledge of invasive fungal disease in ChinaChen, Yijian; Huang, Xiaojun; Qiu, Haibo; Cheng, Linling; Yu, Yunsong; Ma, Xiaochun; Feng, Sizhou; Li, Qi; Wu, Depei; Huang, Wenxiang; Chen, Dechang; Lv, Xiaoju; Hu, Jianda; Wang, Jingbo; Li, Jiabin; Yang, Wenjie; Zhan, Qingyuan; Sun, Bing; Wang, Minggui
2019Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trialYuan, Jinyi; Mo, Biwen; Ma, Zhuang; Lv, Yuan; Cheng, Shih-Lung; Yang, Yanping; Tong, Zhaohui; Wu, Renguang; Sun, Shenghua; Cao, Zhaolong; Wu, Jufang; Zhu, Demei; Chang, Liwen; Zhang, Yingyuan; Zhao, Li; Wang, Xiongbiao; Wang, Xuefen; Wang, Dexi; Li, Xiangyang; Peng, Yiqiang; Liang, Yongjie; Liu, Hua; Xiao, Zuke; Lv, Xiaoju; Wu, Shiman; Dai, Yuanrong; Huang, Yijiang; Hu, Zhenghong; Qiu, Chen; Li, Xi; Zhang, Suiyang; Li, Wenpu; Liu, Shuang; Shi, Yi; Xiong, Chang; Kuang, Jiulong; Xiu, Qingyu; Cui, Shehuai; Li, Jianguo; Lin, Qichang; Huang, Wenxiang; Wan, Yixin; Li, Qimangu; Shen, Ce; Xiao, Yi; Wu, Xiaoju; Chuang, Yin Ching; Perng, Wann Cherng; Tsao, Shih-Ming; Hsu, Jeng-Yuan; Wang, Chin-Chou; Wang, Jen-Hsien; Yeh, Pen-Fang; Lin, His-Hsun; Kuo, P. H.; Lin, Ming-Shian; Su, Wei-Juin
2019Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in ChinaSun, Jian; Ding, Huiguo; Chen, Guofeng; Wang, Guiqiang; Wei, Lai; Zhang, Jiming; Xie, Qing; Wan, Mobin; Tang, Hong; Chen, Shijun; Gao, Zhiliang; Wang, Yuming; Zhang, Dazhi; Huang, Wenxiang; Sheng, Jifang; Ning, Qin; Yang, Dongliang; Lu, Jian; Pan, Chen; Yang, Yuxiu; Wang, Jue; Sun, Chuanzhen; Wang, Qixin; Hou, Jinlin